135 related articles for article (PubMed ID: 21518024)
21. LL-37 but Not 25-Hydroxy-Vitamin D Serum Level Correlates with Healing of Venous Leg Ulcers.
Krejner A; Litwiniuk M; Grzela T
Arch Immunol Ther Exp (Warsz); 2017 Oct; 65(5):455-461. PubMed ID: 27663530
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D deficiency is associated with diagnosis and severity of childhood atopic dermatitis.
Wang SS; Hon KL; Kong AP; Pong HN; Wong GW; Leung TF
Pediatr Allergy Immunol; 2014 Feb; 25(1):30-5. PubMed ID: 24383670
[TBL] [Abstract][Full Text] [Related]
23. NACHT, LRR, and PYD domains-containing Protein 3 and LL-37: prognostic value of new biomarkers in community-acquired pneumonia.
Zhu C; Zhou Y; Zhu J; Liu Y; Sun M
J Bras Pneumol; 2019 Aug; 45(4):e20190001. PubMed ID: 31482943
[TBL] [Abstract][Full Text] [Related]
24. Increased serum antimicrobial peptide LL-37 and HBD-2 combined with 25-hydroxyvitamin D3 deficiency in infants with pertussis.
Chen S; Ye W; Zheng W; Xu Z; Chen Y; Jin L
J Infect Dev Ctries; 2020 Oct; 14(10):1164-1169. PubMed ID: 33175712
[TBL] [Abstract][Full Text] [Related]
25. Comparison of skin hydration evaluation sites and correlations among skin hydration, transepidermal water loss, SCORAD index, Nottingham Eczema Severity Score, and quality of life in patients with atopic dermatitis.
Hon KL; Wong KY; Leung TF; Chow CM; Ng PC
Am J Clin Dermatol; 2008; 9(1):45-50. PubMed ID: 18092843
[TBL] [Abstract][Full Text] [Related]
26. Cathelicidin LL-37 bloodstream surveillance is down regulated during septic shock.
Barbeiro DF; Barbeiro HV; Zampieri FG; César Machado MC; Torggler Filho F; Gomes Cunha DM; Goulart AC; Velasco IT; Monteiro da Cruz Neto L; Possolo de Souza H; Pinheiro da Silva F
Microbes Infect; 2013 May; 15(5):342-6. PubMed ID: 23328115
[TBL] [Abstract][Full Text] [Related]
27. Cathelicidin and human β-defensin 2 in bronchoalveolar lavage fluid of children with pulmonary tuberculosis.
Cakir E; Torun E; Gedik AH; Umutoglu T; Aktas EC; Topuz U; Deniz G
Int J Tuberc Lung Dis; 2014 Jun; 18(6):671-5. PubMed ID: 24903937
[TBL] [Abstract][Full Text] [Related]
28. The human cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections.
Méndez-Samperio P
Peptides; 2010 Sep; 31(9):1791-8. PubMed ID: 20600427
[TBL] [Abstract][Full Text] [Related]
29. Clinical Signs, Staphylococcus and Atopic Eczema-Related Seromarkers.
Hon KL; Tsang KY; Kung JS; Leung TF; Lam CW; Wong CK
Molecules; 2017 Feb; 22(2):. PubMed ID: 28216598
[TBL] [Abstract][Full Text] [Related]
30. Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum.
Howell MD; Jones JF; Kisich KO; Streib JE; Gallo RL; Leung DY
J Immunol; 2004 Feb; 172(3):1763-7. PubMed ID: 14734759
[TBL] [Abstract][Full Text] [Related]
31. [Cathelicidin LL-37. A central factor in the pathogenesis of inflammatory dermatoses?].
Schauber J; Ruzicka T; Rupec RA
Hautarzt; 2008 Jan; 59(1):72-4. PubMed ID: 18209993
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D nutritional status and vitamin D regulated antimicrobial peptides in serum and pleural fluid of patients with infectious and noninfectious pleural effusions.
Amado CA; García-Unzueta MT; Fariñas MC; Santos F; Ortiz M; Muñoz-Cacho P; Amado JA
BMC Pulm Med; 2016 Jul; 16(1):99. PubMed ID: 27392908
[TBL] [Abstract][Full Text] [Related]
33. Vitamin D and Cathelicidin (LL-37) Status in Patients with Type 2 Diabetes and Staphylococcus aureus Nasal Carriage.
Plataki MN; Vamvoukaki R; Samonis G; Bikis C; Gorgomiti M; Papadakis JA; Maraki S; Kofteridis DP
Rev Diabet Stud; 2021; 17(1):30-37. PubMed ID: 34289005
[TBL] [Abstract][Full Text] [Related]
34. Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn's disease, and clinical prognosis in inflammatory bowel disease.
Tran DH; Wang J; Ha C; Ho W; Mattai SA; Oikonomopoulos A; Weiss G; Lacey P; Cheng M; Shieh C; Mussatto CC; Ho S; Hommes D; Koon HW
BMC Gastroenterol; 2017 May; 17(1):63. PubMed ID: 28494754
[TBL] [Abstract][Full Text] [Related]
35. The host defense peptide LL-37 a possible inducer of the type I interferon system in patients with polymyositis and dermatomyositis.
Lu X; Tang Q; Lindh M; Dastmalchi M; Alexanderson H; Popovic Silwerfeldt K; Agerberth B; Lundberg IE; Wick C
J Autoimmun; 2017 Mar; 78():46-56. PubMed ID: 28012697
[TBL] [Abstract][Full Text] [Related]
36. Effect of narrowband ultraviolet B therapy on serum vitamin D and cathelicidin (LL-37) in patients with chronic plaque psoriasis.
Al-Mutairi N; Shaaban D
J Cutan Med Surg; 2014; 18(1):43-8. PubMed ID: 24377473
[TBL] [Abstract][Full Text] [Related]
37. Serum level of cathelicidin LL-37 in patients with active tuberculosis and other infectious diseases.
Majewski K; Agier J; Kozłowska E; Brzezińska-Błaszczyk E
J Biol Regul Homeost Agents; 2017; 31(3):731-736. PubMed ID: 28956425
[TBL] [Abstract][Full Text] [Related]
38. High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.
Wang G; Mishra B; Epand RF; Epand RM
Biochim Biophys Acta; 2014 Sep; 1838(9):2160-72. PubMed ID: 24463069
[TBL] [Abstract][Full Text] [Related]
39. Changes of antimicrobial peptide mRNA expression in atopic eczema following phototherapy.
Gambichler T; Skrygan M; Tomi NS; Altmeyer P; Kreuter A
Br J Dermatol; 2006 Dec; 155(6):1275-8. PubMed ID: 17107401
[TBL] [Abstract][Full Text] [Related]
40. The Self-administered Eczema Area and Severity Index in children with moderate to severe atopic dermatitis: better estimation of AD body surface area than severity.
van Velsen SG; Knol MJ; Haeck IM; Bruijnzeel-Koomen CA; Pasmans SG
Pediatr Dermatol; 2010; 27(5):470-5. PubMed ID: 20796235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
